Table 1.
Patient baseline characteristics
| |
LD (n=30) |
SD (n=27) |
p value |
|---|---|---|---|
| Agea (years) |
48 (29-62) |
47 (26-69) |
0.821 |
| Male sex (%) |
15 (50%) |
13 (48%) |
1.002 |
| Ethnicity | |||
| Caucasian | 26 (87%) | 20 (74%) | |
| Asian | 2 (7%) | 5 (19%) | 0.322 |
| Hispanic | 1 (3%) | 0 (0%) | |
| African-American |
1 (3%) |
2 (7%) |
|
| ALT (U/L)b |
91 ± 69 |
97 ± 85 |
0.931 |
| HCV RNA (log IU/ml)b |
6.3 ± 0.82 |
5.9 ± 1.02 |
0.141 |
| Genotype | |||
| 2 | 21 (70%) | 13 (48%) | 0.1122 |
| 3 |
9 (30%) |
14 (52%) |
|
| Liver Histology | |||
| HAI inflammatory scorec | 8 (3-13) | 8 (5-14) | 0.363 |
| Ishak fibrosis scorec | 2 (0-6) | 1 (0-6) | 0.923 |
a
Mean (range)
b
Mean ± standard deviation
c
Median (range)
1
Student's t-test
2
Fisher's exact test
3
Mann-Whitney's U test